◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CHE

Chemed Corp (CHE) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL CARE FACILITIES · DATA UPDATED 2026-08-15

Chemed Corp (CHE) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Cincinnati, United States with about 15,811 employees. Its market capitalization is roughly $7 billion. In the fiscal year ended 2025-12-31, CHE reported $2.5B in revenue and $265M in net income.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.

Interactive charts & full statements → Open the CHE valuation workbench →

CHE Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$2.6B$2.5B$2.4B$2.3B$2.1B$2.1B$2.1B$1.9B$1.8B$1.7B$1.6B$1.5B$1.5B$1.4B$1.4B$1.4B$1.3B$1.2B$1.1B$1.1B$1.0B
Gross Profit$790M$758M$854M$799M$765M$770M$701M$617M$555M$516M$461M$456M$422M$405M$397M$385M$375M$356M$338M$333M$288M
Gross Margin %30.4%30.0%35.1%35.3%35.8%36.0%33.7%31.9%31.1%31.0%29.3%29.5%28.9%28.6%27.7%28.4%29.2%29.9%29.4%30.3%28.3%
Operating Income (EBIT)$349M$338M$366M$341M$343M$343M$390M$257M$244M$113M$179M$184M$168M$133M$156M$154M$144M$126M$133M$123M$105M
Operating Margin %13.5%13.4%15.1%15.0%16.1%16.0%18.7%13.3%13.7%6.8%11.3%11.9%11.6%9.4%10.9%11.3%11.2%10.6%11.6%11.2%10.3%
Net Income$275M$265M$302M$273M$250M$269M$319M$220M$206M$98M$109M$110M$99M$77M$89M$86M$82M$74M$71M$64M$51M
Net Margin %10.6%10.5%12.4%12.0%11.7%12.6%15.4%11.3%11.5%5.9%6.9%7.1%6.8%5.5%6.2%6.3%6.4%6.2%6.2%5.8%5.0%
EBITDA$432M$422M$464M$414M$393M$411M$455M$311M$283M$157M$215M$217M$202M$168M$191M$184M$175M$160M$155M$138M$129M
Earnings Per Share (EPS)$19.80$18.42$19.89$17.93$16.53$16.85$19.48$13.31$12.23$5.86$6.48$6.33$5.57$4.16$4.62$4.10$3.55$3.24$3.04$2.55$1.90
Shares Outstanding (M)13M14M15M15M15M16M16M17M17M17M17M17M18M19M19M21M23M23M23M25M27M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CHE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$673M$658M$639M$625M$619M$647M$640M$606M
Gross Profit$204M$199M$206M$181M$185M$216M$234M$210M
Gross Margin %30.4%30.2%32.2%28.9%29.8%33.5%36.6%34.6%
Operating Income (EBIT)$89M$85M$101M$75M$68M$95M$114M$92M
Operating Margin %13.2%12.9%15.7%12.0%11.0%14.6%17.8%15.2%
Net Income$68M$66M$77M$64M$52M$72M$90M$76M
Net Margin %10.1%10.1%12.0%10.3%8.5%11.1%14.1%12.5%
EBITDA$101M$106M$122M$102M$88M$112M$136M$117M
Earnings Per Share (EPS)$5.04$4.85$5.48$4.42$3.59$4.86$6.02$5.02
Shares Outstanding (M)13M14M14M15M15M15M15M15M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CHE Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$390M$388M$417M$330M$310M$309M$489M$301M$287M$162M$135M$172M$110M$151M$132M$174M$86M$161M$112M$100M$99M
Capital Expenditures (CapEx)$66M$63M$50M$57M$57M$59M$59M$53M$53M$64M$40M$44M$44M$29M$35M$30M$26M$21M$26M$27M$22M
Free Cash Flow (FCF)$324M$325M$368M$273M$253M$250M$430M$248M$234M$98M$96M$127M$67M$122M$97M$145M$60M$139M$86M$73M$77M
FCF Margin %12.5%12.9%15.1%12.1%11.8%11.7%20.7%12.8%13.1%5.9%6.1%8.2%4.6%8.6%6.8%10.7%4.7%11.7%7.5%6.6%7.5%
Dividends Paid$33M$32M$27M$24M$22M$22M$21M$20M$19M$17M$16M$16M$14M$14M$13M$13M$12M$8M$6M$6M$6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CHE Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$85M$88M$134M$83M$139M$33M$165M$91M
Capital Expenditures (CapEx)$16M$17M$16M$17M$16M$13M$13M$14M
Free Cash Flow (FCF)$69M$71M$117M$66M$123M$19M$152M$77M
FCF Margin %10.3%10.8%18.3%10.6%19.8%3.0%23.8%12.7%
Dividends Paid$8M$8M$8M$9M$7M$7M$7M$7M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CHE Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$1.6B$1.6B$1.7B$1.7B$1.4B$1.3B$1.4B$1.3B$976M$920M$880M$852M$860M$894M$860M$796M$830M$819M$761M$772M$793M
Cash & Cash Equivalents$40M$75M$178M$264M$74M$33M$163M$6M$5M$11M$15M$15M$14M$84M$70M$38M$50M$112M$4M$5M$29M
Total Liabilities$749M$661M$550M$560M$643M$719M$534M$542M$384M$380M$356M$339M$409M$445M$406M$382M$368M$342M$389M$408M$372M
Total Debt (Short + Long-Term)$76M$52M$42M$54M$136M$223M$36M$129M$103M$101M$109M$91M$148M$184M$175M$167M$159M$152M$210M$225M$151M
Total Shareholders' Equity$831M$979M$1.1B$1.1B$799M$623M$901M$727M$591M$540M$524M$513M$451M$449M$453M$414M$462M$477M$372M$364M$421M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CHE viewer.

Other Companies in MEDICAL CARE FACILITIES

← CHDNAll “C” companiesCHEC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.